期刊文献+

电压门控性钠通道Nav1.7及其特异性阻断剂在神经病理性痛中的研究进展 被引量:1

Progress of Voltage Gated Sodium Channel Nav1.7 and Its Specific Blockers in Neuropathic Pain
下载PDF
导出
摘要 电压门控性钠通道(voltage gated sodium channel,Nav)在痛觉的产生和传导中具有重要作用。在痛觉传导通路中,Nav1.7选择性表达于小直径外周感觉神经元和交感神经节神经元,可通过强化阈下刺激并设定Nav1.8和Nav1.9激活开放的阈值,从而影响神经元兴奋性。该综述将重点阐述由Nav1.7通道基因突变所致的神经病理性痛的研究进展。Nav1.7可作为治疗疼痛的有效靶点,高选择性的Nav1.7阻断剂将对治疗疼痛具有重要的临床应用价值。 Voltage gated sodium channels(Nav) play important roles in generation and conduction of pain.In pain conduction pathway,Nav1.7 is selectively expressed in smalldiameter peripheral somatic sensory neurons and sympathetic ganglion neurons.Navl.7modulates neuronal excitability through amplifing subthreshold of depolarizations and setting up the thresholds of Navl.8 and Navl.9.This review will focus on the progress of neuropathic pain caused by mutations in Navl.7.Navl.7 can be used as an effective target for the treatment of pain.Highly selective Navl.7 blockers will be of great clinical value in the treatment of pain.
作者 王川 单彬 王琼 张海林 WANG Chuan SHAN Bin WANG Qiong ZHANG Hai-lin(Department of Pharmacology, Hebei Medical University, Shijiazhuang, 050017, China Department of Pharmacy, the Forth Hospital of Hebei Medical University, Shijiazhuang, 050011, China)
出处 《神经药理学报》 2015年第5期49-56,共8页 Acta Neuropharmacologica
基金 国家自然科学基金资助项目(No.31171097 No.31270882) 国家重点基础研究发展计划(973计划)(No.2013CB531302) 河北省自然科学基金资助项目(No.C2014206419) 教育部留学回国人员科研启动基金项目(No.2013-693) 河北省高等学校科学技术研究项目重点项目(No.ZD2015007)
关键词 神经病理性痛 电压门控性钠通道 Nav1.7 钠通道阻断剂 背根神经节 通道结构 neuropathic pain voltage gated sodium channel Nav1.7 sodium channel blocker dorsal root ganglia channel structure
  • 相关文献

参考文献2

二级参考文献24

  • 1韩济生.消除疼痛的最终理想还有多远——一种离子通道病显示出疼痛的根源[J].生理科学进展,2007,38(3):199-201. 被引量:2
  • 2Goldin AL, Batch RI, Caldwell JH, et al. Nomenclature of voltage-gated sodium channels[J]. Neuron,2000,28(2) :365 - 368
  • 3Yu FH, Catterall WA. Overvies of voltage-gated sodium channel family [J]. Genome Biol,2003,4(3) :207 - 213
  • 4Catterall WA, C, oldin AL, Waxman SG, et al. Interational union of pharmacology XL Ⅷ Nommclature and structure-function relationships of vdtage-gated sodium channelsⅧ Phanncol Hev,2005,57(4) : 397 - 409
  • 5Joost PH, Stephen G, Waxman, et al. Mutations in sodium-channel gene SCN9A cause a spectrum of human genetic pain disorders[J] .The Journal of Clinical Investigation,2007,117,117(12) :3603 -3609
  • 6Theodore R, Curtains, James R, et al. Slow closed-state inactivation: a novel mechanism underlying ramp currents in cells expressing the hNE/PN1 sodium channe[J].The Joumal of Neuroscience,1998,18(23) :9607 - 9619
  • 7Cestele S, Qu Y, Rochat H, et al. Voltage sensor-trapping: enhanced activation of sodium channels by β-scorpion toxin bound to the S3-S4 loop in domainⅡ[J]., Neuron, 1998,21 (4) :919 - 931
  • 8Rogers JC, Qu Y, Tanada TN, et al. Molecular determinants of high affinity binding of a-corpion toxin and sea anemone toxin in the S3-S4 extracellularloop in domain IV of the Na+ channel a-subunit[J]. Biol Chem, 1996,271(5) : 15950 - 15962
  • 9Yang Y, Wang Y, Li S, et al. Mutations in SCN9A, encoding a sodium channel alpha subunit, in patients with primary erythermalgia[J]. Med Genet,2004,41 (3) : 171 - 174
  • 10Cox JJ, Reimann F, Nicholas AK, et al. An SCN9A chamelopethy causes congenital inability to experience pain[J].Nature,2006,444(12):894-898

共引文献7

同被引文献3

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部